Cholesteryl group- and acryloyl group-bearing pullulan nanogel to deliver BMP2 and FGF18 for bone tissue engineering

Biomaterials

Volumn 33, Issue 30, 2012, Pages 7613-7620

  Fujioka Kobayashi, Masako ^a,b   Ota, Masato S ^a   Shimoda, Asako ^a,c   Nakahama, Ken Ichi ^a   Akiyoshi, Kazunari ^a,c   Miyamoto, Youji ^b   Iseki, Sachiko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Acryloyl group modified cholesterol bearing pullulan (CHPOA); Bone regeneration; Drug delivery; Osteoblasts; Recombinant human bone morphogenetic protein 2 (BMP2); Recombinant human fibroblast growth factor 18 (FGF18)

Indexed keywords

ACTIVE MATERIAL; BONE DEFECT; BONE RECONSTRUCTION; BONE REGENERATION; BONE REPAIR; BONE TISSUE ENGINEERING; CONTROLLED RELEASE; COST-EFFICIENCY; DRUG DELIVERY SYSTEM; GOLD STANDARDS; GROWTH FACTOR; HUMAN BONE MORPHOGENETIC PROTEIN; HUMAN FIBROBLAST; LONG-TERM PERIOD; NANOGELS; OSTEOPROGENITOR CELLS; PULLULANS; SKULL BONE;

DEFECTS; DRUG DELIVERY; HYDROGELS; NANOSTRUCTURED MATERIALS; OSTEOBLASTS; POLYETHYLENE GLYCOLS; PROTEINS; TISSUE ENGINEERING;

BONE;

FIBROBLAST GROWTH FACTOR 18; PULLULAN; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ACRYLOYL GROUP MODIFIED CHOLESTEROL BEARING PULLULAN NANOGEL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE REMODELING; BONE TISSUE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; FEMALE; HISTOLOGY; HYDROGEL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SKULL DEFECT; STEM CELL; TISSUE ENGINEERING;

ACRYLATES; ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CELL LINEAGE; CHOLESTEROL; DRUG DELIVERY SYSTEMS; FIBROBLAST GROWTH FACTORS; GLUCANS; HUMANS; MICE; MICE, INBRED C57BL; OSTEOBLASTS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; RECOMBINANT PROTEINS; RHODAMINES; TISSUE ENGINEERING; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 84864963987     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.06.075     Document Type: Article

References (43)

1. Hollier L.H., Sharabi S.E., Koshy J.C., Stal S. Facial trauma: general principles of management. J Craniofac Surg 2010, 21:1051-1053.
2. Neovius E., Engstrand T. Craniofacial reconstruction with bone and biomaterials: review over the last 11 years. J Plast Reconstr Aesthet Surg 2010, 63:1615-1623.
3. Miles B.A., Goldstein D.P., Gilbert R.W., Gullane P.J. Mandible reconstruction. Curr Opin Otolaryngol Head Neck Surg 2010, 18:317-322.
4. Moreau J.L., Caccamese J.F., Coletti D.P., Sauk J.J., Fisher J.P. Tissue engineering solutions for cleft palates. J Oral Maxillofac Surg 2007, 65:2503-2511.
5. Tanaka E., Ishino Y., Sasaki A., Hasegawa T., Watanabe M., Dalla-Bona D.A., et al. Fibroblast growth factor-2 augments recombinant human bone morphogenetic protein-2-induced osteoinductive activity. Ann Biomed Eng 2006, 34:717-725.
6. Pérez-Sánchez M.J., Ramírez-Glindon E., Lledó-Gil M., Calvo-Guirado J.L., Pérez-Sánchez C. Biomaterials for bone regeneration. Med Oral Patol Oral Cir Bucal 2010, 15:e517-e522.
7. Wozney J.M. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 1992, 32:160-167.
8. Naganawa T., Xiao L., Coffin J.D., Doetschman T., Sabbieti M.G., Agas D., et al. Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice. J Cell Biochem 2008, 103:1975-1988.
9. Herford A.S. rhBMP-2 as an option for reconstructing mandibular continuity defects. J Oral Maxillofac Surg 2009, 67:2679-2684.
10. Boraiah S., Paul O., Hawkes D., Wickham M., Lorich D.G. Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report. Clin Orthop Relat Res 2009, 467:3257-3262.
11. Dupont K.M., Boerckel J.D., Stevens H.Y., Diab T., Kolambkar Y.M., Takahata M., et al. Synthetic scaffold coating with adeno-associated virus encoding BMP2 to promote endogenous bone repair. Cell Tissue Res 2012, 347:575-588.
12. Cahill K.S., Chi J.H., Day A., Claus E.B. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA 2009, 302:58-66.
13. Govender S., Csimma C., Genant H.K., Valentin-Opran A., Amit Y., Arbel R., et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002, 84:2123-2134.
14. Kamolratanakul P., Hayata T., Ezura Y., Kawamata A., Hayashi C., Yamamoto Y., et al. Nanogel-based scaffold delivery of prostaglandin E(2) receptor (EP4) specific agonist in combination with low dosage of growth factor heals critical size bone defect. Arthritis Rheum 2011, 63:1021-1033.
15. Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 2009, 8:235-253.
16. Liu Z., Lavine K.J., Hung I.H., Ornitz D.M. FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. Dev Biol 2007, 302:80-91.
17. Ohbayashi N., Shibayama M., Kurotaki Y., Imanishi M., Fujimori T., Itoh N., et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev 2002, 16:870-879.
18. Fakhry A., Ratisoontorn C., Vedhachalam C., Salhab I., Koyama E., Leboy P., et al. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential. Bone 2005, 36:254-266.
19. Chen F.M., Zhang M., Wu Z.F. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010, 31:6279-6308.
20. Schliephake H., Weich H.A., Dullin C., Gruber R., Frahse S. Mandibular bone repair by implantation of rhBMP-2 in a slow release carrier of polylactic acid-an experimental study in rats. Biomaterials 2008, 29:103-110.
21. Matsusaki M., Akashi M. Novel functional biodegradable polymer IV: pH-sensitive controlled release of fibroblast growth factor-2 from a poly(gamma-glutamic acid)-sulfonate matrix for tissue engineering. Biomacromolecules 2005, 6:3351-3356.
22. Yilgor P., Hasirci N., Hasirci V. Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. J Biomed Mater Res A 2010, 93:528-536.
23. Rajam M., Pulavendran S., Rose C., Mandal A.B. Chitosan nanoparticles as a dual growth factor delivery system for tissue engineering applications. Int J Pharm 2011, 410:145-152.
24. Lin C.C., Metters A.T. Bifunctional monolithic affinity hydrogels for dual-protein delivery. Biomacromolecules 2008, 9:789-795.
25. Takemoto S., Morimoto N., Kimura Y., Taira T., Kitagawa T., Tomihata K., et al. Preparation of collagen/gelatin sponge scaffold for sustained release of bFGF. Tissue Eng Part A 2008, 14:1629-1638.
26. Akiyoshi K., Deguchi S., Moriguchi N., Yamaguchi S., Sunamoto J. Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles. Macromolecules 1993, 26:3062-3068.
27. Akiyoshi K., Kobayashi S., Shichibe S., Mix D., Baudys M., Kim S.W., et al. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin. J Control Release 1998, 54:313-320.
28. Kato N., Hasegawa U., Morimoto N., Saita Y., Nakashima K., Ezura Y., et al. Nanogel-based delivery system enhances PGE2 effects on bone formation. J Cell Biochem 2007, 101:1063-1070.
29. Hayashi C., Hasegawa U., Saita Y., Hemmi H., Hayata T., Nakashima K., et al. Osteoblastic bone formation is induced by using nanogel-crosslinking hydrogel as novel scaffold for bone growth factor. J Cell Physiol 2009, 220:1-7.
30. Shimoda A, Sawada SI, Kano A, Maruyama A, Moquin A, Winnik FM, et al. Dual crosslinked hydrogel nanoparticles by nanogel bottom-up method for sustained-release delivery. Colloids Surf B Biointerfaces, in press.
31. Hirata K., Tsukazaki T., Kadowaki A., Furukawa K., Shibata Y., Moriishi T., et al. Transplantation of skin fibroblasts expressing BMP-2 promotes bone repair more effectively than those expressing Runx2. Bone 2003, 32:502-512.
32. Alles N., Soysa N.S., Hayashi J., Khan M., Shimoda A., Shimokawa H., et al. Suppression of NF-kappaB increases bone formation and ameliorates osteopenia in ovariectomized mice. Endocrinology 2010, 151:4626-4634.
33. Sena K., Morotome Y., Baba O., Terashima T., Takano Y., Ishikawa I. Gene expression of growth differentiation factors in the developing periodontium of rat molars. J Dent Res 2003, 82:166-171.
34. Rodda S.J., McMahon A.P. Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development 2006, 133:3231-3244.
35. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999, 21:70-71.
36. Kempen D.H., Creemers L.B., Alblas J., Lu L., Verbout A.J., Yaszemski M.J., et al. Growth factor interactions in bone regeneration. Tissue Eng Part B Rev 2010, 16:551-566.
37. Sasaki Y., Akiyoshi K. Nanogel engineering for new nanobiomaterials: from chaperoning engineering to biomedical applications. Chem Rec 2010, 10:366-376.
38. Nishikawa T., Akiyoshi K., Sunamoto J. Macromolecular complexation between bovine serum albumin and the self-assembled hydrogel nanoparticle of hydrophobized polysaccharides. J Am Chem Soc 1996, 118:6110-6115.
39. Hasegawa U., Sawada S., Shimizu T., Kishida T., Otsuji E., Mazda O., et al. Raspberry-like assembly of cross-linked nanogels for protein delivery. J Control Release 2009, 140:312-317.
40. Shimoda A., Yamamoto Y., Sawada S., Akiyoshi K. Biodegradable nanogel-integrated hydrogels for sustained protein delivery. Macromol Res 2012, 20:266-270.
41. Reinhold M.I., Abe M., Kapadia R.M., Liao Z., Naski M.C. FGF18 represses noggin expression and is induced by calcineurin. J Biol Chem 2004, 279:38209-38219.
42. Wan D.C., Pomerantz J.H., Brunet L.J., Kim J.B., Chou Y.F., Wu B.M., et al. Noggin suppression enhances in vitro osteogenesis and accelerates in vivo bone formation. J Biol Chem 2007, 282:26450-26459.
43. Miyahara T, Nyan M, Shimoda A, Yamamoto Y, Kuroda S, Shiota M, et al. Exploitation of a novel polysaccharide nanogel cross-linking membrane for guided bone regeneration (GBR). J Tissue Eng Regen Med, in press.